Literature DB >> 3282066

Benefit/risk ratio of new drugs: for whom? Discussion paper.

R Palminteri1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3282066      PMCID： PMC1291510          DOI： 10.1177/014107688808100312

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  2 in total

1.  The practicing physician as generator and user of adverse reaction data.

Authors:  J Venulet
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1986-07

2.  Useless drugs are not placebos: lessons from flunarizine and cinnarizine.

Authors:  J R Laporte; D Capella
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321
  2 in total
  1 in total

Review 1.  Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.

Authors:  M Schäfer-Korting; M H Schmid; H C Korting
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.